Major depressive disorder screening

Major depressive disorder Microchapters

Home

Major Depressive Disorder (Patient Information)

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Major depressive disorder from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Substance/Medication-induced Depressive Disorder

Depressive Disorder due to a Medical Condition

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Psychotherapy

ECT

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Follow-up

Follow-Up

Case Studies

Case #1

Major depressive disorder screening On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Major depressive disorder screening

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:  Mitra Chitsazan, M.D.[2]

## Overview

[edit | edit source]

According to the U.S. Preventive Services Task Force (USPSTF), screening for major depressive disorder is recommended in children and adolescents 12 to 18 years of age, in older adults, and in pregnant women (at least once during pregnancy and again 4-8 weeks after delivery).

## Screening

[edit | edit source]

* The U.S. Preventive Services Task Force (USPSTF) does not recommend routine screening for major depressive disorder (MDD) in children 7 to 11 years of age. [1]
* The USPSTF recommends screening for MDD in children and adolescents 12 to 18 years of age. [1]
* The Patient Health Questionnaire for Adolescents ([PHQ-A]) and the Beck Depression Inventory for Primary Care ([BDI-PC]) can be used.
* The U.S. Preventive Services Task Force (USPSTF) and American Academy of Family Physicians recommend screening for MDD in the general adult population.
* The USPSTF, American Academy of Family Physicians, American Academy of Pediatrics, and American College of Obstetricians and Gynecologists recommend screening all postpartum women for depression. [1] [2] [1] [3]
* The USPSTF recommends that all pregnant women should be screened for depression at least once during the perinatal period. It recommends screening at least once during pregnancy and again 4-8 weeks after delivery. [1]
* A validated screening instrument such as the Edinburgh Postnatal Depression Scale or the PHQ-9[4] can be used.
* In older adults, instruments such as PHQ-2, PHQ-9[4], Cornell Scale for Depression in Dementia, or Geriatric Depression Scale are appropriate screening tools.
* When any of the screening instruments is positive for possible depression, the diagnosis needs to be confirmed according to the criteria from the Diagnostic and Statistical Manual of Mental Disorders, 5th ed.

## References

[edit | edit source]

1. ↑ 1.0 1.1 1.2 1.3 1.4 Siu AL, US Preventive Services Task Force (USPSTF). Bibbins-Domingo K, Grossman DC, Baumann LC, Davidson KW; et al. (2016). "Screening for Depression in Adults: US Preventive Services Task Force Recommendation Statement". JAMA. 315 (4): 380–7. doi:10.1001/jama.2015.18392. PMID 26813211.CS1 maint: Multiple names: authors list (link)
2. ↑ "Overview of AAFP Clinical Preventive Services Recommendations".
3. ↑ "The American College of Obstetricians and Gynecologists Committee Opinion no. 630. Screening for perinatal depression". Obstet Gynecol. 125 (5): 1268–1271. 2015. doi:10.1097/01.AOG.0000465192.34779.dc. PMID 25932866.
4. ↑ 4.0 4.1 Spitzer RL, Kroenke K, Williams JB (1999). "Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire". JAMA. 282 (18): 1737–44. doi:10.1001/jama.282.18.1737. PMID 10568646.CS1 maint: Multiple names: authors list (link)